DE69132340D1 - Kondensiertes pyrazinderivat - Google Patents

Kondensiertes pyrazinderivat

Info

Publication number
DE69132340D1
DE69132340D1 DE69132340T DE69132340T DE69132340D1 DE 69132340 D1 DE69132340 D1 DE 69132340D1 DE 69132340 T DE69132340 T DE 69132340T DE 69132340 T DE69132340 T DE 69132340T DE 69132340 D1 DE69132340 D1 DE 69132340D1
Authority
DE
Germany
Prior art keywords
represent
alkyl
pyrazine derivative
nitro
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132340T
Other languages
English (en)
Other versions
DE69132340T2 (de
Inventor
Shuichi Sakamoto
Jun-Ya Ohmori
Hirokazu Kubota
Masao Sasamata
Masamichi Okada
Kazuyuki Hidaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE69132340D1 publication Critical patent/DE69132340D1/de
Application granted granted Critical
Publication of DE69132340T2 publication Critical patent/DE69132340T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69132340T 1990-11-06 1991-11-01 Kondensiertes pyrazinderivat Expired - Fee Related DE69132340T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30087990 1990-11-06
JP6959291 1991-01-11
JP13382891 1991-03-29
JP18324891 1991-06-27
PCT/JP1991/001498 WO1992007847A1 (en) 1990-11-06 1991-11-01 Fused pyrazine derivative

Publications (2)

Publication Number Publication Date
DE69132340D1 true DE69132340D1 (de) 2000-08-31
DE69132340T2 DE69132340T2 (de) 2001-02-08

Family

ID=27465151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132340T Expired - Fee Related DE69132340T2 (de) 1990-11-06 1991-11-01 Kondensiertes pyrazinderivat

Country Status (14)

Country Link
US (1) US5283244A (de)
EP (1) EP0556393B1 (de)
JP (1) JP2550456B2 (de)
KR (1) KR0132903B1 (de)
AT (1) ATE194985T1 (de)
AU (1) AU656154B2 (de)
CA (1) CA2095444C (de)
DE (1) DE69132340T2 (de)
DK (1) DK0556393T3 (de)
ES (1) ES2150417T3 (de)
GR (1) GR3034629T3 (de)
HU (2) HU221425B (de)
RU (1) RU2095352C1 (de)
WO (1) WO1992007847A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
US6057304A (en) 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
ATE157977T1 (de) 1992-10-13 1997-09-15 Warner Lambert Co Chinoxalinderivate als eaa antagonisten
PH31122A (en) * 1993-03-31 1998-02-23 Eisai Co Ltd Nitrogen-containing fused-heterocycle compounds.
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
WO1995018616A2 (en) * 1994-01-03 1995-07-13 Acea Pharm Inc 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
WO1996010023A1 (fr) * 1994-09-27 1996-04-04 Yamanouchi Pharmaceutical Co., Ltd. Derive de 1,2,3,4-tetrahydroquinoxalindione
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19532050A1 (de) * 1995-08-31 1997-03-06 Basf Ag Pyrrolyl-tetrahydrochinoxalindione, ihre Herstellung und Verwendung zur Bekämpfung von Krankheiten
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
TW448171B (en) * 1996-06-06 2001-08-01 Yamanouchi Pharma Co Ltd Imidazole-substituted quinoxalinedione derivatives
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
CN1230889A (zh) 1996-09-27 1999-10-06 吉尔福特药业有限公司 NAALADase组合物和治疗谷氨酸异常及在动物中产生神经元活性的方法
PT934326E (pt) * 1996-10-24 2006-08-31 Novartis Ag Acidos aminoalcanofosfonicos substituidos
AP982A (en) * 1997-02-27 2001-07-16 Pfizer Quinoxalinediones.
HUP0003612A3 (en) * 1997-02-27 2003-04-28 Pfizer Quinoxalinediones and pharmaceutical compositions containing them
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
BR9814628A (pt) 1997-11-11 2001-11-27 Ono Pharmaceutical Co Derivados de pirazina fundidos
PT1255734E (pt) 2000-01-24 2006-09-29 Neurosearch As Derivados de isatina com actividade neurotrofica
CA2612419C (en) * 2005-06-23 2017-06-13 Array Biopharma Inc. Process for preparing benzimidazole compounds
AP2408A (en) * 2006-04-21 2012-05-30 Pfizer Prod Inc Pyridine[3,4-B]pyrazinones.
US7601716B2 (en) * 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
PT2076506E (pt) 2007-01-16 2010-12-10 Purdue Pharma Lp Compostos de piperidina substituídos nos grupos heterocíclicos como ligandos orl-1
ES2593706T3 (es) 2007-08-31 2016-12-12 Purdue Pharma Lp Compuestos de piperidina, de tipo quinoxalina sustituida, y usos de los mismos
US20100113461A1 (en) 2008-10-29 2010-05-06 Gilead Palo Alto, Inc. Substituted heterocyclic compounds
WO2010074807A1 (en) 2008-10-30 2010-07-01 Gilead Palo Alto, Inc. 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
EP2338492A1 (de) 2009-12-24 2011-06-29 Universidad del Pais Vasco Verfahren und Zusammensetzung zur Behandlung von Alzheimer
EP4403184A1 (de) 2021-09-15 2024-07-24 University of The Ryukyus Pharmazeutische zusammensetzung zur verwendung bei der behandlung von kognitivem verfall, übergewicht oder adipositas
EP4403185A1 (de) 2021-09-15 2024-07-24 University of The Ryukyus Pharmazeutische zusammensetzung zur behandlung von kognitivem verfall oder zur behandlung von übergewicht oder adipositas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
AU656154B2 (en) 1995-01-27
AU8766691A (en) 1992-05-26
WO1992007847A1 (en) 1992-05-14
CA2095444C (en) 2001-06-19
US5283244A (en) 1994-02-01
HUT64324A (en) 1993-12-28
EP0556393B1 (de) 2000-07-26
EP0556393A4 (en) 1994-04-13
DK0556393T3 (da) 2000-10-16
KR0132903B1 (ko) 1998-04-17
GR3034629T3 (en) 2001-01-31
RU2095352C1 (ru) 1997-11-10
HU9301298D0 (en) 1993-09-28
HU221425B (en) 2002-10-28
ES2150417T3 (es) 2000-12-01
EP0556393A1 (de) 1993-08-25
DE69132340T2 (de) 2001-02-08
CA2095444A1 (en) 1992-05-07
ATE194985T1 (de) 2000-08-15
JP2550456B2 (ja) 1996-11-06
HU211310A9 (en) 1995-11-28

Similar Documents

Publication Publication Date Title
DE69132340D1 (de) Kondensiertes pyrazinderivat
IL97403A0 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them
DE68920556D1 (de) Substituierte Thiazole und ihre Anwendung als Fungizide.
ES2088537T3 (es) Derivados de piranil cianoguanidina.
ES2161713T3 (es) Derivado de metotrexato.
ES2110213T3 (es) Derivado de n-acilglutamina.
DK0591058T3 (da) Ellipticinderivater med antitumoraktivitet
ATE210642T1 (de) 2-substituierte vitamin-d3-derivate
ES2065994T3 (es) Beta-dicetonas substituidas.
DK451389D0 (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
ES2156901T3 (es) Antidepresor.
ES2140524T3 (es) Derivados de metotrexato.
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
ATE84303T1 (de) Cysteinderivate.
DK0658555T3 (da) Pyridazinonderivater, fremgangsmåder til fremstilling deraf samt anvendelse deraf
ATE177106T1 (de) Ymidothiophosphat-derivat und insektizid, nematozid und akarizid enthalted dasselbe als aktiven bestandteil.
DE60316219D1 (de) Farbphotographisches lichtempfindliches Silberhalogenidmaterial
PL324070A1 (en) Novel compounds of ellipticin, method of obtaining them and pharmaceutical preparations containing such compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee